Tag: CAPA

Using CAPA to Drive Long-Term Corrective Actions After Deviation Spikes Using CAPA to Drive Long-Term Corrective Actions After Deviation Spikes In the realm of clinical research, organizations frequently encounter protocol deviations that may affect participant safety, data integrity, and regulatory compliance. Addressing these deviations effectively is crucial not just for immediate rectification but also for…

Read More “Using CAPA to Drive Long-Term Corrective Actions After Deviation Spikes” »

Integrating Reconsent and Corrective Actions Into Deviation Workflows Integrating Reconsent and Corrective Actions Into Deviation Workflows In clinical trials, the management of protocol deviations is an essential aspect of maintaining compliance and ensuring patient safety. In this article, we will provide a comprehensive step-by-step tutorial on how to integrate reconsent processes and corrective actions into…

Read More “Integrating Reconsent and Corrective Actions Into Deviation Workflows” »

Training Investigators on When Reconsent Is Mandated vs Optional Training Investigators on When Reconsent Is Mandated vs Optional Clinical trials are governed by stringent regulations and ethical standards, requiring careful consideration of participant rights during the entire study duration. Reconsenting participants is a crucial aspect of maintaining adherence to ethical standards and regulatory requirements. This…

Read More “Training Investigators on When Reconsent Is Mandated vs Optional” »

Case Studies: Reconsent Decisions That Protected Subjects and Data Integrity Case Studies: Reconsent Decisions That Protected Subjects and Data Integrity The integrity of clinical trials hinges not only on robust methodologies but also on the ethical treatment of participants. In the domain of clinical research, there are instances where trial amendments or study protocol modifications…

Read More “Case Studies: Reconsent Decisions That Protected Subjects and Data Integrity” »

Balancing Subject Burden With Ethical and Regulatory Obligations Balancing Subject Burden With Ethical and Regulatory Obligations Clinical trials are paramount for advancing medical knowledge and therapeutic development. However, they also present unique challenges in maintaining ethical standards while ensuring stringent regulatory compliance. A particularly sensitive area is the management of patient enrollment in clinical trials,…

Read More “Balancing Subject Burden With Ethical and Regulatory Obligations” »

Aligning Reconsent Requirements Across Global Regulatory Regions Aligning Reconsent Requirements Across Global Regulatory Regions In the evolving landscape of clinical research, ensuring alignment in reconsent requirements across different regulatory bodies is critical for compliance and the integrity of clinical trials. As professionals engaged in clinical operations, regulatory affairs, and medical affairs, understanding how variations exist…

Read More “Aligning Reconsent Requirements Across Global Regulatory Regions” »

Reconsent Strategies in DCT, eConsent and Remote Visit Models In the evolving landscape of clinical trials, particularly in fields such as schizophrenia clinical trials, reconsent strategies are becoming increasingly critical. This guide aims to provide clinical operations, regulatory affairs, and medical affairs professionals in the US, UK, and EU with a comprehensive walkthrough on implementing…

Read More “Reconsent Strategies in DCT, eConsent and Remote Visit Models” »

Corrective Measures for Eligibility, Dosing and Visit Deviations Corrective Measures for Eligibility, Dosing and Visit Deviations In clinical trials, maintaining compliance with the protocol is crucial to ensuring the validity of the study. Protocol deviations, such as eligibility, dosing, and visit deviations, necessitate corrective measures for the integrity of the clinical trial. This comprehensive guide…

Read More “Corrective Measures for Eligibility, Dosing and Visit Deviations” »

Documenting Reconsent Discussions and Updated Informed Consent Forms Documenting Reconsent Discussions and Updated Informed Consent Forms In the domain of clinical trials, particularly those regulated by the FDA, EMA, and MHRA, maintaining robust ethical standards is paramount. One of the critical components of adhering to these ethical standards is the process of informed consent. This…

Read More “Documenting Reconsent Discussions and Updated Informed Consent Forms” »

IRB/IEC Expectations for Reconsent Following Major Deviations IRB/IEC Expectations for Reconsent Following Major Deviations In clinical research, maintaining compliance with ethical and regulatory standards is paramount. The role of Institutional Review Boards (IRB) and Independent Ethics Committees (IEC) is critical in ensuring participant safety and informed consent throughout the clinical trial process. This article provides…

Read More “IRB/IEC Expectations for Reconsent Following Major Deviations” »